12-Month Post-Marketing Safety Surveillance Data Confirms the Excellent Safety and Tolerability Profile of Fiber Choice® (Chewable Inulin Fiber), a Well-Studied, Chewable Prebiotic Fiber Supplement
IM HealthScience®, innovators of medical foods and dietary supplements, today announced favorable results from a real-world, 12-month, post-marketing safety surveillance study for Fiber Choice® prebiotic fiber supplements
U.S. Gastroenterologists Endorse Fiber Choice® Chewable Prebiotic Fiber Supplement With a “#1-Recommended” Rating
In a national survey, the Fiber Choice® line of chewable prebiotic fiber tablets and gummies achieved the #1 share of gastroenterologist (GE) recommendations
Results of Patient-Reported Outcomes Study, Presented at the Annual Meeting of the American College of Gastroenterology (ACG), Provide Confirmatory Real-World Evidence of Improved Bowel Regularity, Rapid Symptom Improvement, and Patient Satisfaction with Fiber Choice® Chewable Prebiotic Fiber Supplement
IM HealthScience® (IMH), innovators of medical foods and dietary supplements, today announced final, positive results of a patient-reported outcomes study entitled CIFPRO, (Chewable Inulin Fiber Patient Reported Outcomes™), a real-world study of patients who took Fiber Choice® Chewable prebiotic fiber supplement.
Fiber Choice® Chewable Prebiotic Fiber Supplement Achieves #1-Recommended Status From Gastroenterologists Nationwide
IM HealthScience® (IMH), innovators of medical foods and dietary supplements, today announced a high-quality and replicated nationwide survey conducted among a representative and projectible sample of U.S. gastroenterologists, which revealed Fiber Choice® as the #1-recommended chewable prebiotic fiber brand.